SCHEMBL2118607

SCHEMBL2118607

COc1ccc(S(=O)(=O)Nc2cc(C)cc(-c3ccc(OC)cn3)c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 3/20 0.54
GABRG2 P18507 1/20 0.54
GABRB3 P28472 1/20 0.54
GABRA3 P34903 1/20 0.54
PIK3CB P42338 1/20 0.54
CYP19A1 P11511 1/20 0.52
PKM P14618 1/20 0.52
KDM4E B2RXH2 1/20 0.52
ALDH1A1 P00352 1/20 0.52
SYK P43405 1/20 0.51
KIT P10721 1/20 0.49
LMNA P02545 3/20 0.49
GAA P10253 1/20 0.49
MAPK1 P28482 1/20 0.49
HTT P42858 2/20 0.48
POLB P06746 1/20 0.48
MAPT P10636 1/20 0.48
TSHR P16473 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
KEAP1 Q14145 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2118551 0.96 PIK3CB (0.50) FFAR4GABRG2GABRB3GABRA3PIK3CB
SCHEMBL2118552 0.91 FFAR4 (0.51) FFAR4GABRG2GABRB3GABRA3PIK3CB
SCHEMBL2120549 0.88 STAT3 (0.48) FFAR4GABRG2GABRB3GABRA3PIK3CB
SCHEMBL2118102 0.87 PIK3CB (0.41) FFAR4GABRG2GABRB3GABRA3PIK3CB
SCHEMBL2116904 0.86 LMNA (0.41) FFAR4GABRG2GABRB3GABRA3PIK3CB
SCHEMBL2120108 0.83 LMNA (0.39) FFAR4GABRG2GABRB3GABRA3PIK3CB
SCHEMBL2119745 0.83 FFAR4 (0.64) FFAR4GABRG2GABRB3GABRA3CYP19A1
SCHEMBL2117686 0.81 FFAR4 (0.61) FFAR4GABRG2GABRB3GABRA3CYP19A1
SCHEMBL2118641 0.79 PIK3CB (0.49) FFAR4PIK3CBKDM4EALDH1A1KIT
SCHEMBL2117823 0.78 PIK3CB (0.52) FFAR4GABRG2GABRB3GABRA3PIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095024-A1 TOLUIDINE SULFONAMIDES AND THEIR USE ELARA PHARMACEUTICALS GMBH (DE) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095024-A1 TOLUIDINE SULFONAMIDES AND THEIR USE HIF1AN, HIF1A, EGLN2 FFAR4 4059/4885GABRG2 4604/4885GABRB3 4684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.